What Is Cardio-Oncology? And When Does a Survivor Need It?
Cardio-oncology is the shared work of protecting the heart before, during, and long after cancer treatment. Here is what these clinicians actually do, and which exposures usually earn a referral.
Cardio-oncology is the field where cancer care and cardiovascular care meet. Its purpose is to let people receive the cancer treatment that works while protecting the heart — during treatment, and for the decades of survivorship that follow.
What a cardio-oncology clinician actually does
Before or during treatment: estimate baseline cardiovascular risk, obtain a baseline echocardiogram and sometimes biomarkers, optimize blood pressure and other risk factors, and advise oncology on monitoring cadence so treatment can continue safely.
After treatment: interpret changes in heart function against exposure history, decide when imaging or referral is needed, manage cardiomyopathy, coronary and valve disease, arrhythmia, and hypertension in the specific context of prior cancer therapy, and coordinate with oncology and primary care.
Exposures that most often prompt cardiovascular follow-up
Anthracyclines such as doxorubicin (dose-related risk of left-ventricular dysfunction), HER2-targeted therapy such as trastuzumab (usually reversible dysfunction, higher risk when combined with anthracyclines), and chest or mediastinal radiation (coronary disease, valve disease, pericardial disease, conduction problems — often appearing many years later).
Also: VEGF and tyrosine-kinase inhibitors (hypertension, sometimes reduced function), immune checkpoint inhibitors (uncommon but serious myocarditis), androgen-deprivation therapy and some endocrine therapies (metabolic and cardiovascular risk shifts), and stem-cell transplant (multiple cardiovascular late effects).
Guideline detail differs between societies and updates regularly. Life Spark's clinician guideline comparison surfaces publication dates and disagreements rather than blending them into one number.
Symptoms worth raising promptly
New or worsening breathlessness with ordinary activity, waking short of breath, swelling in the legs or abdomen, chest pressure with exertion, palpitations that persist, fainting, or a sudden drop in exercise tolerance.
These are not proof of heart disease — anemia, deconditioning, thyroid problems, and lung effects can all produce them. They are a reason to be evaluated rather than to wait for the next scheduled visit. This article does not diagnose the cause of any individual symptom.
If there is no cardio-oncology clinic nearby
Most survivorship cardiovascular care is deliverable in general cardiology and primary care, provided the treatment exposures are known. What travels poorly is the exposure history — cumulative anthracycline dose, radiation field and dose, which targeted agents.
That is the practical case for carrying a written treatment summary: it converts a generic cardiovascular visit into an exposure-aware one.
Frequently asked questions
- Do all cancer survivors need to see a cardiologist?
- No. Referral is generally driven by treatment exposures, existing cardiovascular risk factors, abnormal imaging or biomarkers, or new symptoms.
- How soon after treatment should heart function be checked?
- It depends on the drugs and doses received and on radiation exposure; society guidance differs, so the cadence should be set with the treating team against the actual exposure history.